No, it is recent upgrade. the old target is $5, then move to $6, right now is $7!!!
Consolidation, go ALU!!!
Hi, Real Investor
Tell me what do you invest here, invest your money or your time to post the fraud post all time in GNBT? You need to take the medicine or visit doctor!
Do a simple google search with key words: Oral Lyn, India, Target price; you will get recent analyst report on Oral LYn and Generex (2013-11-27). I believe every GNBT investor wait for that great MOMENT. Because we bought GNBT at $10/share, $6/share, $3/share, $1/share, $0.5/share, $0.1/share and $0.03/share! Oral Lyn and AE37 are our dreams!!!
1-3 months Indian decision on Oral Lyn is going to send GNBT to sky!!!
Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer. COMETRIQ is also involved in various other cancer indications, including two ongoing Phase III pivotal trials in metastatic castration-resistant prostate cancer; and two additional Phase III pivotal trials in metastatic hepatocellular cancer and metastatic renal cell cancer. In addition, the company has a portfolio of other novel compounds that address serious unmet medical needs. Exelixis, Inc. has collaborations with Bristol-Myers Squibb Company, Sanofi, Genentech, Inc., GlaxoSmithKline, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds.
1.4 billions chinese population wait for ALU's G4, think about how big chinese market!!!
I believe ALU will back up with its new CEO.
TSL got Chinese governoment support, look at its contracts, most of them from the governoment.
We are now at $13.5, down from $17.84 two weeks ago for no reason!!!
I believe this is a consolidation before TSL move higher.
Should be closed higher
Back up soon!!!